ProfileGDS4718 / 1557905_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 46% 44% 57% 52% 49% 80% 76% 48% 53% 50% 42% 51% 75% 73% 77% 65% 49% 77% 76% 69% 53% 53% 53% 50% 43% 66% 43% 64% 44% 74% 76% 74% 49% 41% 79% 76% 69% 57% 48% 60% 46% 74% 75% 76% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.3078846
GSM549102patient 115, normal, homogenized [OPG study]5.1970844
GSM549104patient 119, normal, homogenized [OPG study]5.9485557
GSM549108patient 138, normal, homogenized [OPG study]5.6832652
GSM549119patient 077, normal, homogenized [OPG study]5.4756949
GSM549133patient 032, cancer, homogenized [OPG study]8.0369280
GSM549139patient 042, cancer, homogenized [OPG study]7.4977676
GSM549099patient 107, normal, homogenized [OPG study]5.4099548
GSM549109patient 139, normal, homogenized [OPG study]5.6998753
GSM549110patient 046, normal, homogenized [OPG study]5.5389850
GSM549114patient 063, normal, homogenized [OPG study]5.0570942
GSM549122patient 082, normal, homogenized [OPG study]5.6052951
GSM549134patient 033, cancer, homogenized [OPG study]7.2952375
GSM549136patient 036, cancer, homogenized [OPG study]7.2528873
GSM549140patient 044, cancer, homogenized [OPG study]7.6317877
GSM549111patient 047, normal, homogenized [OPG study]6.4687465
GSM549113patient 057, normal, homogenized [OPG study]5.4069149
GSM549132patient 031, cancer, homogenized [OPG study]7.5720577
GSM549137patient 038, cancer, homogenized [OPG study]7.522676
GSM549142patient 047, cancer, homogenized [OPG study]6.7665669
GSM549100patient 110, normal, homogenized [OPG study]5.6675253
GSM549107patient 135, normal, homogenized [OPG study]5.6740353
GSM549115patient 068, normal, homogenized [OPG study]5.6120353
GSM549116patient 072, normal, homogenized [OPG study]5.5013350
GSM549120patient 078, normal, homogenized [OPG study]5.1506343
GSM549131patient 030, cancer, homogenized [OPG study]6.5895866
GSM549118patient 074, normal, homogenized [OPG study]5.1103743
GSM549129patient 027, cancer, homogenized [OPG study]6.4333864
GSM549123patient 088, normal, homogenized [OPG study]5.1566844
GSM549124patient 006, cancer, homogenized [OPG study]7.1477574
GSM549126patient 015, cancer, homogenized [OPG study]7.4627576
GSM549128patient 025, cancer, homogenized [OPG study]7.3513674
GSM549103patient 117, normal, homogenized [OPG study]5.523949
GSM549117patient 073, normal, homogenized [OPG study]5.0256441
GSM549138patient 041, cancer, homogenized [OPG study]7.7976379
GSM549141patient 045, cancer, homogenized [OPG study]7.5067576
GSM549130patient 028, cancer, homogenized [OPG study]6.8054769
GSM549101patient 111, normal, homogenized [OPG study]5.9347657
GSM549105patient 128, normal, homogenized [OPG study]5.42748
GSM549106patient 134, normal, homogenized [OPG study]6.1240460
GSM549112patient 048, normal, homogenized [OPG study]5.2730646
GSM549125patient 011, cancer, homogenized [OPG study]7.1888974
GSM549127patient 024, cancer, homogenized [OPG study]7.45175
GSM549135patient 035, cancer, homogenized [OPG study]7.5243176